These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17230068)

  • 21. Molecular analysis of Turkish Gaucher disease patients: identification of novel mutations in glucocerebrosidase (GBA) gene.
    Emre S; Gürakan F; Yüce A; Rolf A; Scott R; Ozen H
    Eur J Med Genet; 2008; 51(4):315-21. PubMed ID: 18586596
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcome of early-treated type III Gaucher disease patients.
    Lee NC; Chien YH; Wong SL; Sheen JM; Tsai FJ; Peng SF; Leung JH; Chao MC; Shun CT; Hwu WL
    Blood Cells Mol Dis; 2014 Sep; 53(3):105-9. PubMed ID: 24984925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Molecular diagnosis and gene therapy for Gaucher disease].
    Ohashi T
    Nihon Rinsho; 1993 Sep; 51(9):2300-7. PubMed ID: 8411706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Allogenic bone marrow transplantation in severe Gaucher disease.
    Tsai P; Lipton JM; Sahdev I; Najfeld V; Rankin LR; Slyper AH; Ludman M; Grabowski GA
    Pediatr Res; 1992 May; 31(5):503-7. PubMed ID: 1603628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel complex allele and two new point mutations in type 2 (acute neuronopathic) Gaucher disease.
    Sinclair G; Choy FY; Humphries L
    Blood Cells Mol Dis; 1998 Dec; 24(4):420-7. PubMed ID: 9851895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Divergent phenotypes in Gaucher disease implicate the role of modifiers.
    Goker-Alpan O; Hruska KS; Orvisky E; Kishnani PS; Stubblefield BK; Schiffmann R; Sidransky E
    J Med Genet; 2005 Jun; 42(6):e37. PubMed ID: 15937077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adult-type Gaucher disease in children: genetics, clinical features and enzyme replacement therapy.
    Zevin S; Abrahamov A; Hadas-Halpern I; Kannai R; Levy-Lahad E; Horowitz M; Zimran A
    Q J Med; 1993 Sep; 86(9):565-73. PubMed ID: 8255971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Current therapeutic focus in type I Gaucher's disease].
    Pérez Calvo JI; Pastores GM; Isola L; Giraldo P; Bueno Gómez J
    Sangre (Barc); 1994 Feb; 39(1):39-44. PubMed ID: 8197518
    [No Abstract]   [Full Text] [Related]  

  • 29. Miscellaneous non-inflammatory musculoskeletal conditions. Gaucher disease and bone.
    Mikosch P
    Best Pract Res Clin Rheumatol; 2011 Oct; 25(5):665-81. PubMed ID: 22142746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The role of neurogenetics in Gaucher disease.
    Brady RO; Barton NW; Grabowski GA
    Arch Neurol; 1993 Nov; 50(11):1212-24. PubMed ID: 8215980
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Gaucher's disease].
    Hatano Y; Miura AB
    Ryoikibetsu Shokogun Shirizu; 1998; (22 Pt 3):383-5. PubMed ID: 9851168
    [No Abstract]   [Full Text] [Related]  

  • 32. [Gaucher's disease ].
    Belmatoug N; Caubel I; Stirnemann J; Billette de Villemeur T
    J Soc Biol; 2002; 196(2):141-9. PubMed ID: 12360743
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypercoagulability, parkinsonism, and Gaucher disease.
    Rosenbaum H; Aharon-Peretz J; Brenner B
    Semin Thromb Hemost; 2013 Nov; 39(8):928-34. PubMed ID: 24129683
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical and genetic studies of Japanese homozygotes for the Gaucher disease L444P mutation.
    Ida H; Rennert OM; Iwasawa K; Kobayashi M; Eto Y
    Hum Genet; 1999; 105(1-2):120-6. PubMed ID: 10480365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gaucher disease.
    Guggenbuhl P; Grosbois B; Chalès G
    Joint Bone Spine; 2008 Mar; 75(2):116-24. PubMed ID: 17996473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Norrbottnian type of Gaucher disease--clinical, biochemical and molecular biology aspects: successful treatment with bone marrow transplantation.
    Svennerholm L; Erikson A; Groth CG; Ringdén O; Månsson JE
    Dev Neurosci; 1991; 13(4-5):345-51. PubMed ID: 1817041
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular characterization of type 3 (neuronopathic) Gaucher disease in Thai patients.
    Suwannarat P; Keeratichamroen S; Wattanasirichaigoon D; Ngiwsara L; Cairns JR; Svasti J; Visudtibhan A; Pangkanon S
    Blood Cells Mol Dis; 2007; 39(3):348-52. PubMed ID: 17689991
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Allogeneic bone marrow transplantation for primary myelofibrosis after splenectomy].
    Sakashita C; Akiyama H; Mori S; Ohashi K; Sakamaki H
    Rinsho Ketsueki; 2000 Mar; 41(3):206-11. PubMed ID: 10774249
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical and genetic characteristics of Korean patients with Gaucher disease.
    Jeong SY; Park SJ; Kim HJ
    Blood Cells Mol Dis; 2011 Jan; 46(1):11-4. PubMed ID: 20729108
    [TBL] [Abstract][Full Text] [Related]  

  • 40. White vitreous opacities in five patients with Gaucher disease type 3.
    Seehra GK; Eghbali A; Sidransky E; FitzGibbon E
    Am J Med Genet A; 2020 Apr; 182(4):808-812. PubMed ID: 31898869
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.